Showing all 2 results
Levofloxacin Tablets
FreeProduct Composition & Available Portfolio
We manufacture Levofloxacin across the complete, internationally standardized therapeutic spectrum to accommodate customized tissue-saturation requirements and specific treatment durations.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Levofloxacin Hemiandrous / Monohydrate USP / BP / IP 250 mg Oral Solid Film-Coated Tablet Uncomplicated Infections: For standard low-dose management of uncomplicated urinary tract infections (UTIs) and acute bacterial sinusitis. Levofloxacin Hemiandrous / Monohydrate USP / BP / IP 500 mg Oral Solid Film-Coated Tablet The Core Commercial Volume: First-line international standard for community-acquired pneumonia (CAP), skin structures, and acute pyelonephritis. Levofloxacin Hemiandrous / Monohydrate USP / BP / IP 750 mg Oral High-Potency Solid Tablet Intensive High-Dose Short-Course: Calibrated for nosocomial pneumonia, complicated skin infections, and advanced multi-drug resistant (MDR) regimens.
